Apollo Hospitals Enterprise Limited Earnings Summary — Q1 FY2027
Apollo Hospitals Reports Robust Q1 FY27 Growth with 39% Net Profit Surge and Digital Segment Turnaround
Quarterly Business Intelligence
AI Quarterly Scorecard™
Computed deterministically from the last 10 reported quarters.
Quarterly Business Momentum
- Revenue has increased for 7 consecutive quarters.
- Revenue of ₹7,044 Cr is 20.6% higher year-on-year.
- Revenue has compounded at 17.0% annualised over the last 10 quarters.
- Revenue is at its highest level in 10 quarters.
- Net profit has reached its highest level in 10 quarters.
- Net profit of ₹581 Cr is 34.2% above the same quarter last year.
- Profit growth is outpacing revenue growth, pointing to positive operating leverage.
- Net profit has compounded at 44.5% annualised across the period.
- Operating margin stands at 15.5% in Q1 FY2027.
- Operating margin expanded by 93 bps year-on-year.
- Over the last two years operating margin has expanded by 224 bps.
- PBT margin is 11.3%.
- Expense growth of 19.3% remained below revenue growth of 20.6%.
- Operating profit of ₹1,092 Cr is 28.2% higher year-on-year.
- Operating leverage continues to improve.
- 6 of the last 6 measured quarters delivered year-on-year revenue growth.
- Overall quarterly business momentum scores 82/100 (Strong) on the latest 10 quarters.
- Business momentum remains positive heading into the next quarter.
Quarterly Financials
Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %
| Metric | Trend | Latest Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Improving | 7,044 | 6,606 | 6,477 | 6,304 | 5,842 | 5,592 | 5,527 | 5,589 | 5,086 | 4,944 |
| Expenses | Improving | 5,951 | 5,595 | 5,512 | 5,362 | 4,990 | 4,823 | 4,765 | 4,774 | 4,411 | 4,303 |
| Operating Profit | Improving | 1,092 | 1,011 | 965 | 941 | 852 | 770 | 762 | 816 | 675 | 641 |
| Operating Margin | Stable | 15.5% | 15.3% | 14.9% | 14.9% | 14.6% | 13.8% | 13.8% | 14.6% | 13.3% | 13.0% |
| Other Income | Improving | 62 | 54 | 49 | 61 | 54 | 72 | 69 | 44 | 49 | 37 |
| Interest | Stable | 120 | 119 | 113 | 110 | 108 | 115 | 110 | 118 | 116 | 119 |
| Depreciation | Stable | 235 | 224 | 219 | 218 | 215 | 211 | 185 | 185 | 177 | 190 |
| Profit Before Tax | Improving | 799 | 722 | 682 | 675 | 583 | 516 | 536 | 557 | 430 | 368 |
| Tax | Improving | 188 | 170 | 166 | 181 | 142 | 101 | 157 | 162 | 115 | 110 |
| Net Profit | Improving | 581 | 529 | 502 | 477 | 433 | 390 | 372 | 379 | 305 | 254 |
| Net Margin | Improving | 8.2% | 8.0% | 7.8% | 7.6% | 7.4% | 7.0% | 6.7% | 6.8% | 6.0% | 5.1% |
Key Takeaways
- Consolidated revenue grew 20.6% YoY to ₹70,435 million, driven by strong performance across all core segments.
- Healthcare Services remains the primary driver with segment revenue of ₹36,195 million and a healthy 18.9% margin.
- The Digital Health and Pharmacy Distribution segment showed significant improvement, with segment results rising to ₹1,523 million from ₹692 million YoY.
- The Board approved a slump sale of the FMCG and consumer healthcare undertaking from Apollo Healthco to Apollo Consumer Products Limited.
- Proposed merger of Apollo Health and Lifestyle Limited (AHLL) with Kids Clinic India (Cloudnine) to create a large-scale maternity platform was highlighted.
- The company announced the appointment of Price Waterhouse Chartered Accountants LLP as new Statutory Auditors starting from the 2027 AGM.
- Occupancy and ARPOB improvements continue to support hospital segment margins despite ongoing capital expenditure on new projects.
Management Guidance
Management is focused on integrating the omnichannel healthcare ecosystem, specifically scaling the Apollo 24/7 digital platform while maintaining clinical excellence in the hospital division. Growth efforts are directed towards high-utilization hospital beds and expanding the pharmacy distribution network through strategic restructuring.
Sentiment Shift
Improving
The significant profit jump and the doubling of margins in the Digital Health/Pharmacy segment indicate that past investments in the digital ecosystem are now reaching a profitable inflection point.
Outlook
The outlook remains strong as the company executes its 'Composite Scheme of Arrangement' to list the pharmacy and digital business. The divestment of maternity assets into a specialized platform (Cloudnine) is expected to unlock further shareholder value.
From the Annual Report (Key Quotes)
“The Board at its meeting held today transacted the following items... Approved the Unaudited financial results for the three months ended 30th June 2026.”
“The Company's business activity primarily falls within a single reportable business segment namely 'Healthcare Services' and operates primarily in India.”
“The Board approved the grant of additional stock options... representing a total of 46,798 equity shares.”
Official Quarterly Documents
Ask AI about this quarter
This summary is AI-generated from Apollo Hospitals Enterprise Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.